KRO-56428
Ethyl 2-(4-(hydroxymethyl)phenyl)acetate
272130-46-8
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56427
Nalpha-Fmoc-Thr(Ac4-beta-D-Glc)-OH,Fmoc-L-Thr(β-D-Glc(Ac)4)-OH
130548-92-4
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56426
CS-2836,AMG-176,Tapotoclax
1883727-34-1
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56425
CP105696
158081-99-3
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56424
2-Chloro-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)pyrazol-1-yl]pyridine-3-carboxylic acid
2229861-17-8
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56423
Tri-GalNAc(OAc)3,Trans-1,C79H128N10O36,(2R,3R,4R,5R,6R)-3,4-bis(acetyloxy)-6-{4-[(3-{3-[2-amino-3-(2-{[3-(5-{[(2R,3R,4R,5R,6R)-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-acetamidooxan-2-yl]oxy}pentanamido)propyl]carbamoyl}ethoxy)-2-[(2-{[3-(5-{[(2R,3R,4R
1159408-64-6
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56422
AZD-0364,Tizaterkib,CS-2696,(R)-7-(3,4-Difluorobenzyl)-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-6,7-dihydroimidazo[1,2-a]pyrazin-8(5H)-one
2097416-76-5
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56421
Elexacaftor R enantiomer,VX-445 R enantiomer,(R)-N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-(2,2,4-trimethylpyrrolidin-1-yl)nicotinamide
2229860-99-3
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56420
Fmoc-Thr(GalNAc(Ac)3-α-D)-OH,N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine
116783-35-8
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56419
Fmoc-L-Ser(β-D-Gal(Ac)4)-OH,(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2R,3R,4S,5S,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)propanoic acid
96383-44-7
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56418
Z-FF-FMK,Cathepsin L Inhibitor I
105608-85-3
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56417
Fmoc-L-Ser((Ac)3-β-D-GlcNAc)-OH,O-(2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-b-D-glucopyranosyl)-N- a-(fluoren-9-yl-methoxy carbonyl)-L-serine
160067-63-0
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56416
Fmoc-L-Thr(β-D-Gal(Ac)4)-OH
127656-85-3
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56415
Fmoc-Ser(GalNAc(Ac)3-α-D)-OH,N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-?deoxy-α-D-galactopyranosyl)-L-serine
120173-57-1
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56414
N-(1-(2,4-dimethoxyphenyl)-2-S-tritylmercapto)ethylglycine,2-[[1-(2,4-dimethoxyphenyl)-2-tritylsulfanylethyl]amino]acetic acid
823829-31-8
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56413
Fmoc-Asn(GlcNAc(Ac)3-β-D)-OH,GlcNAc L-asparagine,2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranosyl-Fmoc-asparagine
131287-39-3
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56412
Fmoc-L-Ser(β-D-Glc(Ac)4)-OH,2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl-Fmoc serine β-D-Glc(Ac)4)-OH,Nα-(9-fluorenylmethoxycarbonyl)-3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-L-serine
118358-38-6
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56411
(S)-N-Fmoc-2-(6'-heptenyl)glycine,(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)non-8-enoic acid
1058705-57-9
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56410
Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH,(2S,3R)-3-{[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-2-{[(9H-fluoren-9-ylmethoxy) carbonyl]amino}butanoic acid
160168-40-1
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)
KRO-56409
Spermine,N1,N1'-(butane-1,4-diyl)bis(ethane-1,2-diamine),N1,N1'-(butane-1,4-diyl)bis(ethane-1,2-diamine)
35513-90-7
98% min.
scale-up (10-1,000 kg)
98% min.
scale-up (10-1,000 kg)